Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.
Clinical trial NCT03937999 · TERMINATED
Trial details
- NCT number
- NCT03937999
- Sponsor
- Montefiore Medical Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-30
- Primary completion
- 2022-05-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.